Curanex announces senior secured royalty financing
Curanex Pharmaceuticals has secured a $30 million senior secured royalty financing facility. This capital infusion is intended to strengthen liquidity and support ongoing corporate development activities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day